288 related articles for article (PubMed ID: 16051698)
1. Characterization of isoprenaline- and salmeterol-stimulated interactions between beta2-adrenoceptors and beta-arrestin 2 using beta-galactosidase complementation in C2C12 cells.
Carter AA; Hill SJ
J Pharmacol Exp Ther; 2005 Nov; 315(2):839-48. PubMed ID: 16051698
[TBL] [Abstract][Full Text] [Related]
2. Salmeterol, a long-acting beta 2-adrenoceptor agonist mediating cyclic AMP accumulation in a neuronal cell line.
McCrea KE; Hill SJ
Br J Pharmacol; 1993 Oct; 110(2):619-26. PubMed ID: 7902176
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol Efficacy and Bias in the Activation and Kinase-Mediated Desensitization of β2-Adrenergic Receptors.
Gimenez LE; Baameur F; Vayttaden SJ; Clark RB
Mol Pharmacol; 2015 Jun; 87(6):954-64. PubMed ID: 25784721
[TBL] [Abstract][Full Text] [Related]
4. Influence of receptor number on the stimulation by salmeterol of gene transcription in CHO-K1 cells transfected with the human beta2-adrenoceptor.
McDonnell J; Latif ML; Rees ES; Bevan NJ; Hill SJ
Br J Pharmacol; 1998 Oct; 125(4):717-26. PubMed ID: 9831907
[TBL] [Abstract][Full Text] [Related]
5. Non-competitive antagonism of beta(2)-agonist-mediated cyclic AMP accumulation by ICI 118551 in BC3H1 cells endogenously expressing constitutively active beta(2)-adrenoceptors.
Hopkinson HE; Latif ML; Hill SJ
Br J Pharmacol; 2000 Sep; 131(1):124-30. PubMed ID: 10960078
[TBL] [Abstract][Full Text] [Related]
6. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
Chong LK; Cooper E; Vardey CJ; Peachell PT
Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032
[TBL] [Abstract][Full Text] [Related]
7. Salmeterol-induced desensitization, internalization and phosphorylation of the human beta2-adrenoceptor.
January B; Seibold A; Allal C; Whaley BS; Knoll BJ; Moore RH; Dickey BF; Barber R; Clark RB
Br J Pharmacol; 1998 Feb; 123(4):701-11. PubMed ID: 9517390
[TBL] [Abstract][Full Text] [Related]
8. A cell-based assay to assess the persistence of action of agonists acting at recombinant human beta(2) adrenoceptors.
Summerhill S; Stroud T; Nagendra R; Perros-Huguet C; Trevethick M
J Pharmacol Toxicol Methods; 2008; 58(3):189-97. PubMed ID: 18652905
[TBL] [Abstract][Full Text] [Related]
9. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.
Scola AM; Chong LK; Suvarna SK; Chess-Williams R; Peachell PT
Br J Pharmacol; 2004 Jan; 141(1):163-71. PubMed ID: 14662724
[TBL] [Abstract][Full Text] [Related]
10. Inhibition of basal and stimulated release of endothelin-1 from guinea pig tracheal epithelial cells in culture by beta 2-adrenoceptor agonists and cyclic AMP enhancers.
Yang Q; Battistini B; Pelletier S; Sirois P
Inflammation; 2007 Oct; 30(5):136-47. PubMed ID: 17620004
[TBL] [Abstract][Full Text] [Related]
11. Cell-based high-throughput screening assay system for monitoring G protein-coupled receptor activation using beta-galactosidase enzyme complementation technology.
Yan YX; Boldt-Houle DM; Tillotson BP; Gee MA; D'Eon BJ; Chang XJ; Olesen CE; Palmer MA
J Biomol Screen; 2002 Oct; 7(5):451-9. PubMed ID: 14599361
[TBL] [Abstract][Full Text] [Related]
12. Differential contribution of two serine residues of wild type and constitutively active beta2-adrenoceptors to the interaction with beta2-selective agonists.
Kikkawa H; Kurose H; Isogaya M; Sato Y; Nagao T
Br J Pharmacol; 1997 Jul; 121(6):1059-64. PubMed ID: 9249239
[TBL] [Abstract][Full Text] [Related]
13. Comparison of duration of agonist action at beta 1- and beta 2- adrenoceptors in C6 glioma cells: evidence that the long duration of action of salmeterol is specific to the beta 2-adrenoceptor.
McCrea KE; Hill SJ
Mol Pharmacol; 1996 May; 49(5):927-37. PubMed ID: 8622643
[TBL] [Abstract][Full Text] [Related]
14. Beta 2-adrenoceptors mediate a reduction in endothelial permeability in vitro.
Allen MJ; Coleman RA
Eur J Pharmacol; 1995 Feb; 274(1-3):7-15. PubMed ID: 7768283
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of CGP 12177 at the human beta(2)-adrenoceptor.
Baker JG; Hall IP; Hill SJ
Br J Pharmacol; 2002 Oct; 137(3):400-8. PubMed ID: 12237261
[TBL] [Abstract][Full Text] [Related]
16. Agonist and inverse agonist actions of beta-blockers at the human beta 2-adrenoceptor provide evidence for agonist-directed signaling.
Baker JG; Hall IP; Hill SJ
Mol Pharmacol; 2003 Dec; 64(6):1357-69. PubMed ID: 14645666
[TBL] [Abstract][Full Text] [Related]
17. Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells.
Chong LK; Suvarna K; Chess-Williams R; Peachell PT
Br J Pharmacol; 2003 Feb; 138(3):512-20. PubMed ID: 12569076
[TBL] [Abstract][Full Text] [Related]
18. The selectivity of beta-adrenoceptor antagonists at the human beta1, beta2 and beta3 adrenoceptors.
Baker JG
Br J Pharmacol; 2005 Feb; 144(3):317-22. PubMed ID: 15655528
[TBL] [Abstract][Full Text] [Related]
19. In vitro pharmacological characterization of vilanterol, a novel long-acting β2-adrenoceptor agonist with 24-hour duration of action.
Slack RJ; Barrett VJ; Morrison VS; Sturton RG; Emmons AJ; Ford AJ; Knowles RG
J Pharmacol Exp Ther; 2013 Jan; 344(1):218-30. PubMed ID: 23131596
[TBL] [Abstract][Full Text] [Related]
20. Effect of salmeterol on human nasal epithelial cell ciliary beating: inhibition of the ciliotoxin, pyocyanin.
Kanthakumar K; Cundell DR; Johnson M; Wills PJ; Taylor GW; Cole PJ; Wilson R
Br J Pharmacol; 1994 Jun; 112(2):493-8. PubMed ID: 7915610
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]